Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank86
3Y CAGR+12.3%
5Y CAGR+16.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+12.3%/yr
vs +82.1%/yr prior
5Y CAGR
+16.7%/yr
Recent deceleration
Acceleration
-69.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
| Period | Value | YoY Change |
|---|---|---|
| TTM | $249000.00 | 0.0% |
| 2024 | $249000.00 | +27.0% |
| 2023 | $196000.00 | +11.4% |
| 2022 | $176000.00 | +0.6% |
| 2021 | $175000.00 | +52.2% |
| 2020 | $115000.00 | +150.0% |
| 2019 | $46000.00 | +187.5% |
| 2018 | $16000.00 | - |